Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Inotuzumab ozogamicin in individuals with Down syndrome and acute lymphoblastic leukemia.
Journal: Leukemia
Published: December 31, 2025
A multi-institutional report of children with atypical teratoid rhabdoid tumor treated with intensive multimodal therapy.
Journal: Neuro-oncology practice
Published: September 10, 2025
Universal Premedication Does Not Impact Transition to Short-acting Asparaginase or Incidence of Hypersensitivity to Pegylated Asparaginase: A Single-institution Experience.
Journal: Journal of pediatric hematology/oncology
Published: October 24, 2024
A pediatric case of KMT2A-rearranged B-lymphoblastic lymphoma treated with high-risk therapy.
Journal: Leukemia & lymphoma
Published: February 19, 2024
Minimal residual disease predicts outcomes in KMT2A-rearranged but not KMT2A-germline infant acute lymphoblastic leukemia: Report from Children's Oncology Group study AALL0631.
Journal: Pediatric blood & cancer
Published: February 16, 2023
Preclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategy.
Journal: Leukemia
Published: April 30, 2022
Pulmonary toxicity in paediatric patients with relapsed or refractory Hodgkin lymphoma receiving brentuximab vedotin.
Journal: British journal of haematology
Published: September 11, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026